Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Koninklijke Philips N.V.NYSE: PHG

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue declines year over year

Q2 FY2026 cost of revenue of €2.21B fell 5.0% year over year, in line with the -4.7% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.3% from the prior quarter. Over 3 fiscal years it compounded at -2.8% a year.

Context

  • Cost of revenue amounted to 54.8% of revenue in FY2025, down 2.1 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -5.0% toward the trailing-twelve-month pace of -4.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
€2.21B+3.3% QoQ
Last fiscal yearDec 2025
€9.78B-4.6% YoY
LTMJun 2026
€9.55B-4.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.0%——
1 year-4.6%——
3-year CAGR-2.8%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

EUR · from the income statement

Latest · FY2025
9.78B EUR
Year-over-year change
-4.6%
4-year CAGR
-0.5%

Cost of Revenue vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -4.7% is the 9th highest of 10, against a peer median of +2.5%.
  • Cost of revenue amounts to 54.1% of revenue for PHG, versus a peer median of 32.1%.
PHG Competitors
Cost of Revenue for PHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Sep 2026$20.68B USD+2.5%-2.6%42.9%
MDTMedtronic plcLTM Jul 2026$12.51B USD+0.0%+5.9%33.3%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$11.56B USD-1.0%+3.5%57.1%
PHGKoninklijke Philips N.V.LTM Jun 2026€9.55B EUR-4.7%-2.8%54.1%
BSXBoston Scientific CorporationLTM Jun 2026$6.06B USD-11.0%+7.8%28.8%
RMDResMed Inc.LTM Jun 2026$2.2B USD+5.0%+5.6%38.8%
SNNSmith & Nephew plcFY2025$1.96B USD+13.1%+8.9%31.7%
LIVNLivaNova PLCLTM Sep 2026$483.49M USD+13.8%+12.5%32.1%
NPCENeuroPace, Inc.LTM Mar 2026$21.6M USD+1.8%+20.5%21.7%
IRMDIRadimed CorporationLTM Mar 2026$19.99M USD+15.2%+17.5%23.2%
Peer median (excluding PHG) —+2.5%+7.8%32.1%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.